Bompoti Andreana, Papazoglou Andreas S, Moysidis Dimitrios V, Otountzidis Nikolaos, Karagiannidis Efstratios, Stalikas Nikolaos, Panteris Eleftherios, Ganesh Vijayakumar, Sanctuary Thomas, Arvanitidis Christos, Sianos Georgios, Michaelson James S, Herrmann Markus D
Department of Radiology, Peterborough City Hospital, Northwest Anglia NHS Foundation Trust, Peterborough PE3 9GZ, UK.
First Department of Cardiology, AHEPA University Hospital, Aristotle University of Thessaloniki, St. Kiriakidi 1, 54636 Thessaloniki, Greece.
Diagnostics (Basel). 2021 Nov 10;11(11):2075. doi: 10.3390/diagnostics11112075.
Micro-computed tomography (micro-CT) is a promising novel medical imaging modality that allows for non-destructive volumetric imaging of surgical tissue specimens at high spatial resolution. The aim of this study is to provide a comprehensive assessment of the clinical applications of micro-CT for the tissue-based diagnosis of lung diseases. This scoping review was conducted in accordance with the PRISMA Extension for Scoping Reviews, aiming to include every clinical study reporting on micro-CT imaging of human lung tissues. A literature search yielded 570 candidate articles, out of which 37 were finally included in the review. Of the selected studies, 9 studies explored via micro-CT imaging the morphology and anatomy of normal human lung tissue; 21 studies investigated microanatomic pulmonary alterations due to obstructive or restrictive lung diseases, such as chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, and cystic fibrosis; and 7 studies examined the utility of micro-CT imaging in assessing lung cancer lesions ( = 4) or in transplantation-related pulmonary alterations ( = 3). The selected studies reported that micro-CT could successfully detect several lung diseases providing three-dimensional images of greater detail and resolution than routine optical slide microscopy, and could additionally provide valuable volumetric insight in both restrictive and obstructive lung diseases. In conclusion, micro-CT-based volumetric measurements and qualitative evaluations of pulmonary tissue structures can be utilized for the clinical management of a variety of lung diseases. With micro-CT devices becoming more accessible, the technology has the potential to establish itself as a core diagnostic imaging modality in pathology and to enable integrated histopathologic and radiologic assessment of lung cancer and other lung diseases.
微计算机断层扫描(micro-CT)是一种很有前景的新型医学成像方式,它能够以高空间分辨率对手术组织标本进行无损容积成像。本研究的目的是全面评估micro-CT在基于组织的肺部疾病诊断中的临床应用。本范围综述是按照PRISMA范围综述扩展版进行的,旨在纳入每一项报告人类肺组织micro-CT成像的临床研究。文献检索得到570篇候选文章,其中37篇最终被纳入综述。在所选研究中,9项研究通过micro-CT成像探索了正常人类肺组织的形态和解剖结构;21项研究调查了阻塞性或限制性肺部疾病(如慢性阻塞性肺疾病、特发性肺纤维化和囊性纤维化)引起的微观解剖学肺部改变;7项研究考察了micro-CT成像在评估肺癌病变(n = 个体数量未给出)或移植相关肺部改变(n = 个体数量未给出)方面的效用。所选研究报告称,micro-CT能够成功检测多种肺部疾病,提供比常规光学载玻片显微镜更详细和更高分辨率的三维图像,并且还能为限制性和阻塞性肺部疾病提供有价值的容积信息。总之,基于micro-CT的肺部组织结构容积测量和定性评估可用于多种肺部疾病的临床管理。随着micro-CT设备越来越容易获得,该技术有潜力成为病理学中的核心诊断成像方式,并实现对肺癌和其他肺部疾病的组织病理学和放射学综合评估。